General - Press Releases

Date	Title	Company
13-Jun-2022	Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the Group	Businesswire
13-Jun-2022	Elektrofi Raises $40 Million Financing to Establish GMP Manufacturing Capabilities for Upcoming Clinical Studies and Expand Development Pipeline	Businesswire
13-Jun-2022	ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis	Businesswire
13-Jun-2022	Evecxia Therapeutics Announces Leadership Transition to Support Next Phase of Development and Growth	Businesswire
13-Jun-2022	Cortexyme Appoints June Bray to its Board of Directors	Businesswire
13-Jun-2022	Global Neuroimmunology Drug Development Report 2022: Top 20 Neuroimmunology Products Forecast to be Worth $26.6 Billion by 2025 - ResearchAndMarkets.com	Businesswire
13-Jun-2022	BeiGene Announces BRUKINSA™ (zanubrutinib) Is Approved in 50 Markets	Businesswire
13-Jun-2022	ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer	Businesswire
13-Jun-2022	Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS	Businesswire
13-Jun-2022	BeiGene Announces PDUFA Goal Date Extension for U.S. sNDA for BRUKINSA for the Treatment of CLL/SLL	Businesswire
13-Jun-2022	FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Stage IB (≥4 centimeters)-IIIA Non-Small Cell Lung Cancer Following Complete Surgical Resection	Businesswire
13-Jun-2022	Volta Inc. Board of Directors Announces Executive Leadership Team Additions and Key Promotions	Businesswire
13-Jun-2022	BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products	Businesswire
13-Jun-2022	Global Therapeutic Vaccines Market Trends and Forecasts, 2022-2035: Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, RoA - ResearchAndMarkets.com	Businesswire
13-Jun-2022	Global Orphan Diseases Partnering 2010-2022: Deal Trends, Players and Financials for 280 Deals Signed Between the World's Pharma and Biotechnology Companies - ResearchAndMarkets.com	Businesswire
13-Jun-2022	Global Ophthalmics Partnering Analysis Report 2014-2022: Trends, Players and Financials for 550+ Deals - ResearchAndMarkets.com	Businesswire
13-Jun-2022	2021 Healthcare Research Review - ResearchAndMarkets.com	Businesswire
13-Jun-2022	Janssen presenta en la AEH los datos actualizados de teclistamab en pacientes con mieloma múltiple recidivante o refractario	Businesswire
13-Jun-2022	Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne’s Disease Assay	Businesswire
13-Jun-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire